2018 annual financial data
Foghorn Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -26,049,000 USD and net income was -26,337,000 USD.
Operating cash flow was -22,648,000 USD.
Get free Foghorn Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,049,000 USD
- Net income
- -26,337,000 USD
- Operating cash flow
- -22,648,000 USD